Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream [1]

European Journal of Dermatology

Volumn 13, Issue 4, 2003, Pages 413-414

  Peris, Ketty ^a   Micantonio, Tamara ^a   Fargnoli, Maria Concetta ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; AGED; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; KERATOACANTHOMA; LETTER;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; FACIAL DERMATOSES; FEMALE; HUMANS; KERATOACANTHOMA; KERATOSIS;

EID: 0042405040     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Dendorfer M, Oppel T, Wollenberg A, Prinz JC. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 2003; 13: 80-2.
2. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: o report of six cases. Br J Dermatol 2001; 144: 1050-3.
3. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. J Am Acad Dermatol 2002; 47: 571-7.
4. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: Three examples with metastases. Am J Dermatopathol 1993; 15: 332-42.
5. Heaphy MR, Ackerman AB. The nature of solar keratosis: A critical review in historical perspective. J Am Acad Dermatol 2000; 43: 138-50.
6. Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-502.
7. Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C, Lamba S, Lebwohl MG. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol 2002; 47: 553-6.